Horrick Sharma

Dr. Horrick Sharma


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HSHorrick Sharma
Horrick Sharma
Somrita MondalSomrita Mondal
Somrita Mondal
The usage of nanomaterials for cancer treatment has been a popular research focus over the past decade. Nanomaterials, including polymeric nanomaterials, metal nanoparticles, semiconductor quantum dots, and carbon-based nanomaterials such as graphene oxide (GO), have been used for cancer cell imaging, chemotherapeutic drug targeting, chemotherapy, photothermal therapy, and photodynamic therapy. In this review, we discuss the concept of targeted nanoparticles in cancer therapy and summarize the in vivo biocompatibility of graphene-based nanomaterials. Specifically, we discuss in detail the chemistry and properties of GO and provide a comprehensive review of functionalized GO and GO–metal nanoparticle composites in nanomedicine involving anticancer drug delivery and cancer treatment.

17 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Riham BokhtiaRiham Bokhtia
Riham Bokhtia
Siva S. PandaSiva S. Panda
Siva S. Panda
AGAdel S. Girgis
Adel S. Girgis
NSNermin Samir
Nermin Samir
MFMona Fikry
Mona Fikry
AGAmany M. Ghanim
Amany M. Ghanim
New sets of ibuprofen and indomethacin conjugates comprising triazolyl heterocycle were synthesized via click chemistry, adopting an optimized protocol through the molecular hybridization approach affording the targeted agents in good yields. The new non-steroidal anti-inflammatory drug (NSAID) conjugates were designed and synthesized and could be considered as potential drug candidates for the treatment of pain and inflammation. The anti-inflammatory properties were investigated for all the synthesized conjugates. Among 14 synthesized conjugates, four (5a, 5b, 5d, and 5e) were found to have significant anti-inflammatory properties potency 117.6%, 116.5%, 93.8%, and 109.1% in comparison to reference drugs ibuprofen (97.2%) and indomethacin (100%) in the rat paw edema carrageenan test without any ulcerogenic liability. The suppression effect of cytokines IL-6, TNF-α, and iNOS in addition to NO in the LPS-induced RAW264.7 cells supports the promising anti-inflammatory properties observed in the ibuprofen conjugates. In addition, several conjugates showed promising peripheral and central analgesic activity. The selectivity index (SI) of compound 5a (23.096) indicates the significant efficacy and selectivity for COX-2 over COX-1. Molecular modeling (docking and QSAR) studies described the observed biological properties.

17 June 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
HSHorrick Sharma
Horrick Sharma
SMSomrita Mondal
Somrita Mondal
UUUzziah Urquiza
Uzziah Urquiza
CEColter Esparza
Colter Esparza
SBSeth Bartlett
Seth Bartlett
MIMichael A. Ihnat
Michael A. Ihnat
Lactate dehydrogenase-A (LDHA) is the major isoform of lactate dehydrogenases (LDH) that is overexpressed and linked to poor survival in pancreatic ductal adenocarcinoma (PDAC). Despite some progress, current LDH inhibitors have poor structural and physicochemical properties or exhibit unfavorable pharmacokinetics that have hampered their development. The present study reports the synthesis and biological evaluation of a novel class of LDHA inhibitors comprising a succinic acid monoamide motif. Compounds 6 and 21 are structurally related analogs that demonstrated potent inhibition of LDHA with IC50s of 46 nM and 72 nM, respectively. We solved cocrystal structures of compound 21-bound to LDHA that showed that the compound binds to a distinct allosteric site between the two subunits of the LDHA tetramer. Inhibition of LDHA correlated with reduced lactate production and reduction of glycolysis in MIA PaCa-2 pancreatic cancer cells. The lead compounds inhibit the proliferation of human pancreatic cancer cell lines and patient-derived 3D organoids and exhibit a synergistic cytotoxic effect with the OXPHOS inhibitor phenformin. Unlike current LDHA inhibitors, 6 and 21 have appropriate pharmacokinetics and ligand efficiency metrics, exhibit up to 73% oral bioavailability, and a cumulative half-life greater than 4 h in mice.

15 September 2025 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HSHorrick Sharma
Horrick Sharma
TETy Elliott
Ty Elliott
AGAmery Good
Amery Good
PSPragya Sharma
Pragya Sharma
SMSomrita Mondal
Somrita Mondal
MIMichael A. Ihnat
Michael A. Ihnat

1 January 2018 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
HSHorrick Sharma
Horrick Sharma